Research-grade FOXO4 DRI peptide targeting p53 protein interactions to selectively induce apoptosis in senescent cells for vitro studies.
FOXO4-DRI Product Description
FOXO4-DRI is a synthetic D-retro-inverso peptide designed to disrupt FOXO4-p53 protein interactions in laboratory research. This research-grade amino acid sequence selectively targets senescent cells to induce apoptosis, addressing age-related cellular dysfunction observed in aged mice studies.
The lyophilized peptide acts as a senescence regulator, enabling researchers to study apoptosis in senescent cell populations and senescence-associated pathways. FOXO4-DRI demonstrates potential for investigating chemotoxicity responses in vitro research applications. Intended for research use only in qualified laboratory settings.
Our Product Quality Guarantee
Every Limitless Biotech compound undergoes independent testing for endotoxins and sterility, meeting rigorous research standards through our systematic quality protocols and proactive manufacturing processes.
Buy FOXO4-DRI Peptide From Limitless Biotech
Limitless Biotech provides USA-manufactured FOXO4-DRI for sale with verified molecular sequences and purity through comprehensive third-party testing. We ensure research quality with same-day shipping and dedicated customer support for your scientific endeavors.
